About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Phoenix | 240 Studies

Clinical Trials Alzheimer's DiseasePhoenix

Alzheimer's Disease Clinical Trials in Phoenix

Find 240 clinical trials for alzheimer's disease near Phoenix, Arizona. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 240 trials

TerminatedA Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to assess the long term safety, tolerability, and immunogenicity of ACC-001, an investigational vaccine, plus QS-21 in subjects with mild to moderate…NCT00960531·Phoenix, Arizona and 27 others Active not recruitingA Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADThe goal of this clinical trial is to learn if buntanetap/Posiphen works to treat early Alzheimer's disease in adults aged 55-85.NCT06709014·Chandler, Arizona and 77 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingTrial-Ready Cohort-Down Syndrome (TRC-DS)The purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS) is to enroll 120 healthy adults with Down syndrome (DS), between the ages of 25-55, into a trial ready cohort (TRC)…NCT04165109·Phoenix, Arizona and 21 others

CompletedA Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate ADThe purpose of this study is to measure efficacy and safety of three different doses of buntanetap/Posiphen compared with placebo in participants with mild to moderate Alzheimer's…NCT05686044·Gilbert, Arizona and 53 others

CompletedRenew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's TypeA Randomized Pivotal Study of RenewTM NCP-5 for the Treatment of Mild Cognitive Impairment due to Alzheimer's Disease or Mild Dementia of the Alzheimer's Type is a pivotal, single…NCT03721705·Phoenix, Arizona and 11 others

CompletedLong-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's DiseaseTo evaluate the long-term safety and tolerability of idalopirdine (Lu AE58054) as adjunctive therapy to donepezil in patients with mild-moderate Alzheimer's Disease (AD).NCT02079246·Birmingham, Alabama and 257 others

CompletedStudy Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET StudyThis study seeks to confirm a demonstrated treatment effect of intepirdine (RVT-101) as an adjunctive therapy to donepezil for the treatment of subjects with Alzheimer's disease.NCT02585934·Phoenix, Arizona and 196 others

CompletedEARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)12-week, open-label study to evaluate the effectiveness and safety of donepezil hydrochloride in Hispanic patients with mild to moderate Alzheimer's Disease (AD) in the U.S.NCT00230568·Phoenix, Arizona and 34 others

CompletedEfficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's DiseaseThe objectives of the study are to evaluate the safety, tolerability and efficacy of AVP-923 compared to placebo, for the treatment of symptoms of agitation in participants with…NCT01584440·Phoenix, Arizona and 43 others

TerminatedOpen-label Extension for Phase 3 Clinical Trials of SimufilamThe goal of this open-label extension study is to assess long-term safety and tolerability of simufilam 100 mg in subjects who have completed the RETHINK-ALZ or REFOCUS-ALZ Phase…NCT05575076·Chandler, Arizona and 133 others

CompletedA Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's DiseaseThis study seeks to evaluate the efficacy and safety of ABBV-8E12 in participants with early Alzheimer's disease (AD).NCT02880956·Phoenix, Arizona and 67 others

CompletedEffectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive DeclineThis study is designed to determine the effectiveness of florbetapir (18F) in changing patient management and to evaluate the association between scan status and cognitive decline.NCT01703702·Phoenix, Arizona and 56 others

CompletedHuperzine A in Alzheimer's DiseaseThe present study will evaluate the safety and efficacy of the Chinese herb huperzine A in the treatment of Alzheimer's disease (AD) in a randomized controlled trial of its effect…NCT00083590·Birmingham, Alabama and 28 others

RecruitingRepurposing Siponimod for Alzheimer's DiseaseCollaboration with multiple sclerosis (MS) specialty colleagues led us to formulate the central hypothesis that Siponimod could lower the rate of brain atrophy in Alzheimer's…NCT06639282·Phoenix, Arizona

CompletedBapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)This is a multicenter, double-blind, placebo controlled, randomized, outpatient, multiple dose study in male and female patients ages 50 to less than 89 years with mild to…NCT00575055·Birmingham, Alabama and 185 others

CompletedAn Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD SubjectsThis study is being conducted to evaluate the safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype.NCT04770220·Phoenix, Arizona and 94 others

Terminated2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)This is an open-label extension study in patients with mild Alzheimer's disease who have completed participation in the azeliragon Phase 3 (STEADFAST) trial.NCT02916056·Phoenix, Arizona and 70 others

CompletedTricaprilin in Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the safety, tolerability and effectiveness of tricaprilin administered once a day for ninety days in subjects with mild to moderate…NCT00142805·Phoenix, Arizona and 24 others

TerminatedA Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease PatientsThe purpose of this study is to assess the long-term safety and tolerability of bapineuzumab in subjects with Alzheimer Disease who participated in study 3133K1-3001(NCT00676143).NCT00998764·Birmingham, Alabama and 183 others

CompletedA Study of Gantenerumab in Participants With Prodromal Alzheimer's DiseaseThis multi-center, randomized, double-blind, placebo-controlled parallel-group study will evaluate the effect of gantenerumab (RO4909832) on cognition and functioning and the…NCT01224106·Phoenix, Arizona and 138 others

PreviousPage 8 of 12Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia